PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 128 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,102,599 | -65.8% | 2,057,233 | -37.9% | 0.02% | -64.1% |
| Q2 2023 | $134,695,118 | -19.3% | 3,311,904 | -3.9% | 0.06% | -23.8% |
| Q1 2023 | $166,914,445 | +25.3% | 3,445,798 | -1.3% | 0.08% | +21.7% |
| Q4 2022 | $133,201,353 | -40.6% | 3,489,687 | -21.9% | 0.07% | -43.4% |
| Q3 2022 | $224,333,000 | +14.0% | 4,468,775 | -9.0% | 0.12% | +24.5% |
| Q2 2022 | $196,767,000 | +7.4% | 4,911,810 | -0.0% | 0.10% | +34.2% |
| Q1 2022 | $183,270,000 | -5.7% | 4,912,064 | +0.6% | 0.07% | +4.3% |
| Q4 2021 | $194,419,000 | +8.6% | 4,881,214 | +1.4% | 0.07% | +4.5% |
| Q3 2021 | $179,094,000 | -26.8% | 4,813,057 | -16.9% | 0.07% | -28.7% |
| Q2 2021 | $244,743,000 | -5.7% | 5,789,994 | +5.7% | 0.09% | -11.3% |
| Q1 2021 | $259,441,000 | -23.8% | 5,479,202 | -1.7% | 0.11% | -26.4% |
| Q4 2020 | $340,315,000 | +30.6% | 5,576,183 | +0.1% | 0.14% | +14.3% |
| Q3 2020 | $260,502,000 | +1.4% | 5,572,250 | +3.0% | 0.13% | -4.5% |
| Q2 2020 | $256,833,000 | +4.3% | 5,411,573 | -2.0% | 0.13% | -19.5% |
| Q1 2020 | $246,241,000 | -6.3% | 5,520,582 | +0.9% | 0.16% | +18.8% |
| Q4 2019 | $262,728,000 | +43.1% | 5,470,308 | +0.8% | 0.14% | +38.0% |
| Q3 2019 | $183,611,000 | -2.6% | 5,428,649 | +29.6% | 0.10% | 0.0% |
| Q2 2019 | $188,436,000 | +33.7% | 4,188,140 | +11.9% | 0.10% | +33.3% |
| Q1 2019 | $140,923,000 | +27.8% | 3,744,376 | +16.5% | 0.08% | +11.9% |
| Q4 2018 | $110,271,000 | -10.6% | 3,214,293 | +22.4% | 0.07% | +9.8% |
| Q3 2018 | $123,407,000 | +2114.4% | 2,625,634 | +560.0% | 0.06% | +1933.3% |
| Q3 2016 | $5,573,000 | +99.5% | 397,800 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,793,000 | +9.0% | 397,800 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $2,562,000 | -80.1% | 397,800 | 0.0% | 0.00% | -85.7% |
| Q4 2015 | $12,889,000 | +21.4% | 397,800 | 0.0% | 0.01% | +40.0% |
| Q3 2015 | $10,621,000 | -44.5% | 397,800 | 0.0% | 0.01% | -44.4% |
| Q2 2015 | $19,146,000 | -20.9% | 397,800 | 0.0% | 0.01% | -18.2% |
| Q1 2015 | $24,206,000 | +17.5% | 397,800 | 0.0% | 0.01% | +22.2% |
| Q4 2014 | $20,594,000 | +17.6% | 397,800 | 0.0% | 0.01% | +12.5% |
| Q3 2014 | $17,507,000 | +68.4% | 397,800 | 0.0% | 0.01% | +60.0% |
| Q2 2014 | $10,398,000 | 0.0% | 397,800 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $10,398,000 | +62.0% | 397,800 | +5.2% | 0.01% | +66.7% |
| Q4 2013 | $6,420,000 | -20.9% | 378,300 | 0.0% | 0.00% | -25.0% |
| Q3 2013 | $8,118,000 | – | 378,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |